Curcumin Compensates GLP ‐1 Deficiency via the Microbiota‐Bile Acids Axis and Modulation in Functional Crosstalk between TGR5 and FXR in ob/ob Mice
ConclusionsThe findings suggest that Cur may act as a natural TGR5 agonist and FXR antagonist to improve obesity by enhancing GLP-1 release from L-cell expansion via the gut microbiota-BAs-TGR5/FXR axis, and it may serve as a promising therapeutic agent to compensate obesity-related metabolic disorders.
Source: Molecular Nutrition and Food Research - Category: Food Science Authors: Fengyuan Tian,
Tianxi Chen,
Wangda Xu,
Yichang Fan,
Xiaohong Feng,
Qi Huang,
Jie Chen Tags: Research Article Source Type: research
More News: Bile | Eating Disorders & Weight Management | Food Science | Nutrition | Obesity | Study | Turmeric